Arshad M. Khanani

About Arshad M. Khanani

What area of research do you find most exciting right now?

Sustained-release drug delivery systems, optogenetics, and gene therapy to treat retinal diseases.

What advice would you give to your younger self?

Listen, learn, and ask questions.

Nominator comments: “As the principal investigator for many clinical trials, Arshad Khanani is often the first author for many landmark papers, such as The Lancet publication of the GATHER2 results, a study which led to the approval of a new medication for geographic atrophy. His many publications have been cited over 4000 times to date and continue to grow rapidly.”